Feb 4 (Reuters) - Ambu A/S AMBUb.CO:
Q1 REVENUE DKK 1,558M VERSUS DKK 1,510 MILLION YEAR AGO
Q1 EBIT BEFORE SPECIAL ITEMS DKK 164 MILLION VERSUS DKK 243 MILLION YEAR AGO
Q1 ENDOSCOPY SOLUTIONS INCREASED ORGANICALLY BY 14.4% (20.6%)
Q1 RESPIRATORY BUSINESS GROUP POSTED 8.3% (17.7%) ORGANIC GROWTH
Q1 UROLOGY, ENT, & GI BUSINESS GROUP POSTED 21.0% (23.9%) ORGANIC GROWTH
Q1 ANESTHESIA & PATIENT MONITORING POSTED FLAT ORGANIC GROWTH OF -0.1% (17.8%)
2025/26 FINANCIAL GUIDANCE MAINTAINED
Source text: [ID:]
Further company coverage: [AMBUb.CO]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))